Last reviewed · How we verify
HRS-6209 Capsules
HRS-6209 Capsules is a Small molecule drug developed by Jiangsu HengRui Medicine Co., Ltd.. It is currently in Phase 1 development.
At a glance
| Generic name | HRS-6209 Capsules |
|---|---|
| Sponsor | Jiangsu HengRui Medicine Co., Ltd. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer (PHASE1, PHASE2)
- To Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Subjects With HR-Positive/HER2-Negative Solid Tumor (PHASE1)
- A Clinical Study of HRS-6209 Combined With Other Treatment Regimens in Patients With Breast Cancer (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- HRS-6209 Capsules CI brief — competitive landscape report
- HRS-6209 Capsules updates RSS · CI watch RSS
- Jiangsu HengRui Medicine Co., Ltd. portfolio CI
Frequently asked questions about HRS-6209 Capsules
What is HRS-6209 Capsules?
HRS-6209 Capsules is a Small molecule drug developed by Jiangsu HengRui Medicine Co., Ltd..
Who makes HRS-6209 Capsules?
HRS-6209 Capsules is developed by Jiangsu HengRui Medicine Co., Ltd. (see full Jiangsu HengRui Medicine Co., Ltd. pipeline at /company/jiangsu-hengrui-medicine-co-ltd).
What development phase is HRS-6209 Capsules in?
HRS-6209 Capsules is in Phase 1.
Related
- Manufacturer: Jiangsu HengRui Medicine Co., Ltd. — full pipeline
- Compare: HRS-6209 Capsules vs similar drugs
- Pricing: HRS-6209 Capsules cost, discount & access